• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

着色芽生菌病:伊曲康唑治疗期间的组织改变

Chromoblastomycosis: tissue modifications during itraconazole treatment.

作者信息

Purim Kátia Sheylla Malta, Peretti Murilo Calvo, Fillus José, Olandoski Marcia

机构信息

Discipline of Dermatology of the Medical School - Universidade Positivo (UP) - Curitiba (PR), Brazil.

Dermatology Service of theHospital das Clínicas - Universidade Federal do Paraná (HC-UFPR) - Curitiba (PR), Brazil.

出版信息

An Bras Dermatol. 2017 Jul-Aug;92(4):478-483. doi: 10.1590/abd1806-4841.20175466.

DOI:10.1590/abd1806-4841.20175466
PMID:28954095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5595593/
Abstract

BACKGROUND

: Histological and mycological changes during itraconazole use have not been totally established in chromoblastomycosis.

OBJECTIVES

: To evaluate tissue modifications in chromoblastomycosis carriers under itraconazole treatment.

METHODS

: A histological retrospective study of 20 cases of chromoblastomycosis seen at the university hospital at the south of Brazil, during itraconazole 400 mg daily treatment. Patients were classified into two groups: plaque or tumor lesions, and underwent periodic evaluations every four months during three years. Hematoxylin-eosin stain was used to analyze epidermal modifications, inflammatory infiltrate and fibrosis, and Fontana-Masson stain for parasite evaluation.

RESULTS

: Fontana-Masson stain was superior to hematoxylin-eosin stain in fungal count in the epidermis (mean difference=0.14; p<0.05). The most distinct mycosis tissue responses were registered in the dermis. Epidermal thinning, granulomatous infiltrate decrease or disappearance, fibrosis increase and quantitative/morphological changes occurred during treatment.

STUDY LIMITATIONS

: Patients could not be located to have their current skin condition examined.

CONCLUSION

: Parasitic and tissue changes verified in this study can reflect the parasite-host dynamics under itraconazole action.

摘要

背景

在着色芽生菌病中,使用伊曲康唑期间的组织学和真菌学变化尚未完全明确。

目的

评估接受伊曲康唑治疗的着色芽生菌病携带者的组织改变。

方法

对巴西南部大学医院收治的20例着色芽生菌病患者进行组织学回顾性研究,患者接受每日400毫克伊曲康唑治疗。患者分为两组:斑块状或肿瘤样病变组,并在三年期间每四个月进行定期评估。采用苏木精-伊红染色分析表皮改变、炎症浸润和纤维化情况,采用Fontana-Masson染色评估寄生虫。

结果

在表皮真菌计数方面,Fontana-Masson染色优于苏木精-伊红染色(平均差异=0.14;p<0.05)。在真皮中观察到最明显的真菌病组织反应。治疗期间出现表皮变薄、肉芽肿浸润减少或消失、纤维化增加以及数量/形态学变化。

研究局限性

无法找到患者检查其当前皮肤状况。

结论

本研究中证实的寄生虫和组织变化可反映伊曲康唑作用下的寄生虫-宿主动态关系。

相似文献

1
Chromoblastomycosis: tissue modifications during itraconazole treatment.着色芽生菌病:伊曲康唑治疗期间的组织改变
An Bras Dermatol. 2017 Jul-Aug;92(4):478-483. doi: 10.1590/abd1806-4841.20175466.
2
Case Report: Successful Treatment of Chromoblastomycosis Caused by in a Patient with Psoriasis Using Itraconazole and Acitretin.病例报告:伊曲康唑联合阿维 A 治疗银屑病并发暗色丝孢霉病 1 例
Am J Trop Med Hyg. 2018 Jul;99(1):124-126. doi: 10.4269/ajtmh.17-0579. Epub 2018 May 17.
3
Treatment of severe chromoblastomycosis with itraconazole and 5-flucytosine association.伊曲康唑与5-氟胞嘧啶联合治疗重症着色芽生菌病。
Rev Inst Med Trop Sao Paulo. 2010 Nov-Dec;52(6):329-31. doi: 10.1590/s0036-46652010000600008.
4
Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi.伊曲康唑治疗裴氏瓶霉所致着色芽生菌病
Int J Dermatol. 1992 Nov;31(11):805-12. doi: 10.1111/j.1365-4362.1992.tb04252.x.
5
Treatment of chromoblastomycosis with terbinafine: experience with four cases.特比萘芬治疗着色芽生菌病:4例经验
J Dermatolog Treat. 2005 Feb;16(1):47-51. doi: 10.1080/09546630410024538.
6
Chromoblastomycosis imported from Malta.从马耳他输入的着色芽生菌病。
Clin Exp Dermatol. 2003 Sep;28(5):486-7. doi: 10.1046/j.1365-2230.2003.01366.x.
7
Unusual Presentation of Cutaneous Chromoblastomycosis.
Am J Dermatopathol. 2017 Feb;39(2):159-161. doi: 10.1097/DAD.0000000000000612.
8
Chromoblastomycosis: clinical experience and review of literature.着色芽生菌病:临床经验及文献复习。
Int J Dermatol. 2018 Nov;57(11):1351-1355. doi: 10.1111/ijd.14185. Epub 2018 Aug 16.
9
[Pustules from the cow barn].
HNO. 2010 Nov;58(11):1105-7. doi: 10.1007/s00106-010-2105-y.
10
Cyphellophora laciniata: A new etiological agent of chromoblastomycosis.裂褶菌:暗色丝孢霉病的一个新的病因性真菌。
J Mycol Med. 2022 Mar;32(1):101204. doi: 10.1016/j.mycmed.2021.101204. Epub 2021 Sep 9.

引用本文的文献

1
Diagnosis of Cutaneous Chromoblastomycosis and Its Response to Amphotericin B Therapy: A Case Report.皮肤着色芽生菌病的诊断及其对两性霉素B治疗的反应:一例报告
Cureus. 2022 Aug 23;14(8):e28286. doi: 10.7759/cureus.28286. eCollection 2022 Aug.
2
In vivo reflectance confocal microscopy, dermoscopy, high-frequency ultrasonography, and histopathology features in a case of chromoblastomycosis.着色芽生菌病一例的体内反射共聚焦显微镜检查、皮肤镜检查、高频超声检查及组织病理学特征
PLoS Negl Trop Dis. 2022 Mar 3;16(3):e0010226. doi: 10.1371/journal.pntd.0010226. eCollection 2022 Mar.

本文引用的文献

1
CHROMOBLASTOMYCOSIS: A NEGLECTED TROPICAL DISEASE.着色芽生菌病:一种被忽视的热带疾病。
Rev Inst Med Trop Sao Paulo. 2015 Sep;57 Suppl 19(Suppl 19):46-50. doi: 10.1590/S0036-46652015000700009.
2
Chromoblastomycosis due to Fonsecaea pedrosoi: an old wine in a rare bottle.裴氏瓶霉引起的着色芽生菌病:珍稀瓶中的陈酿。
J Infect Dev Ctries. 2015 Mar 15;9(3):325-9. doi: 10.3855/jidc.5312.
3
Clinical and demographic profile of chromoblastomycosis in a referral service in the midwest of São Paulo state (Brazil).巴西圣保罗州中西部一家转诊机构中着色芽生菌病的临床和人口统计学特征
An Bras Dermatol. 2015 Jan-Feb;90(1):140-2. doi: 10.1590/abd1806-4841.20153252.
4
Chromoblastomycosis.着色芽生菌病
Postepy Dermatol Alergol. 2014 Oct;31(5):310-21. doi: 10.5114/pdia.2014.40949. Epub 2014 Oct 22.
5
Revisiting the clinical and histopathological aspects of patients with chromoblastomycosis from the Brazilian Amazon region.重新审视巴西亚马逊地区着色芽生菌病患者的临床和组织病理学特征。
Arch Med Res. 2013 May;44(4):302-6. doi: 10.1016/j.arcmed.2013.04.008. Epub 2013 May 14.
6
Chromoblastomycosis Caused by Fonsecaea pedrosoi.裴氏瓶霉引起的着色芽生菌病
Ann Dermatol. 2011 Aug;23(3):369-74. doi: 10.5021/ad.2011.23.3.369. Epub 2011 Aug 6.
7
Chromoblastomycosis: a clinical and molecular study of 18 cases in Rio de Janeiro, Brazil.着色芽生菌病:巴西里约热内卢 18 例临床与分子研究。
Int J Dermatol. 2011 Aug;50(8):981-6. doi: 10.1111/j.1365-4632.2010.04729.x.
8
Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment.拉丁美洲的植入性真菌感染:流行病学、临床表现、诊断和治疗概述。
Med Mycol. 2011 Apr;49(3):225-36. doi: 10.3109/13693786.2010.539631. Epub 2010 Dec 3.
9
'Unstained' and 'de stained' sections in the diagnosis of chromoblastomycosis: a clinico-pathological study.
Indian J Pathol Microbiol. 2010 Oct-Dec;53(4):666-71. doi: 10.4103/0377-4929.72021.
10
Chromoblastomycosis: study of 27 cases and review of medical literature.着色芽生菌病:27例病例研究及医学文献综述
An Bras Dermatol. 2010 Jul-Aug;85(4):448-54. doi: 10.1590/s0365-05962010000400005.